Noveome Biotherapeutics, Inc. is a pioneering biotechnology company based in Pittsburgh, PA, dedicated to advancing the field of regenerative medicine. Their groundbreaking ST266 biologic, a multi-targeted secretome containing numerous biologically active proteins and factors crucial to healing, holds significant clinical potential for a range of underserved conditions in ophthalmology, neurology, dermatology, and beyond.
With a focus on innovative delivery options and scalable manufacturing, Noveome is committed to developing effective treatments that simulate natural healing processes. Their portfolio covers important ophthalmic indications, and their passionate and diverse team is dedicated to making a positive difference in patients' lives.
Generated from the website